Fjarde Ap Fonden Bristol Myers Squibb CO Transaction History

Fjarde Ap Fonden

$9.04 Billion
Q1 2024

A detailed history of Fjarde Ap Fonden transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fjarde Ap Fonden holds 509,506 shares of BMY stock, worth $25.9 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

509,506

Previous 493,506 3.24%

Holding current value

$25.9 Million

Previous $25.3 Million 9.12%

% of portfolio

0.31%

Previous 0.32%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$47.98 - $54.4 $767,680 - $870,400	16,000 Added 3.24%	509,506 $27.6 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $441,168 - $526,435	9,100 Added 1.88%	493,506 $25.3 Million
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $793,093 - $886,801	-13,700 Reduced 2.75%	484,406 $28.1 Million
Q2 2023 Aug 02, 2023	SELL	$63.71 - $70.74 $1.72 Million - $1.91 Million	-27,000 Reduced 5.14%	498,106 $31.9 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $331,835 - $376,376	-5,050 Reduced 0.95%	525,106 $36.4 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $9.76 Million - $11.6 Million	-142,499 Reduced 21.18%	530,156 $38.1 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $4.26 Million - $4.69 Million	58,600 Added 9.54%	672,655 $51.8 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $1.42 Million - $1.7 Million	23,100 Added 3.91%	614,055 $44.8 Million
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $1.71 Million - $1.99 Million	-31,800 Reduced 5.11%	590,955 $36.8 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $1.31 Million - $1.53 Million	-22,100 Reduced 3.43%	622,755 $36.8 Million
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $2.02 Million - $2.2 Million	-32,700 Reduced 4.83%	644,855 $43.1 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $539,994 - $607,334	9,100 Added 1.36%	677,555 $42.8 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $1.32 Million - $1.5 Million	-22,900 Reduced 3.31%	668,455 $41.5 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $1.52 Million - $1.68 Million	26,400 Added 3.97%	691,355 $41.7 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $586,574 - $685,763	10,700 Added 1.64%	664,955 $39.1 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $1.27 Million - $1.85 Million	-27,400 Reduced 4.02%	654,255 $36.5 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $10.6 Million - $13.8 Million	214,816 Added 46.02%	681,655 $43.8 Million
Q3 2019 Oct 31, 2019	SELL	$42.77 - $50.71 $47,047 - $55,781	-1,100 Reduced 0.24%	466,839 $23.7 Million
Q2 2019 Jul 17, 2019	SELL	$44.62 - $49.34 $437,276 - $483,532	-9,800 Reduced 2.05%	467,939 $21.2 Million
Q1 2019 Apr 29, 2019	BUY	$45.12 - $53.8 $4.13 Million - $4.93 Million	91,600 Added 23.72%	477,739 $22.8 Million
Q4 2018 Jan 31, 2019	SELL	$48.76 - $63.23 $2.25 Million - $2.91 Million	-46,100 Reduced 10.67%	386,139 $20.1 Million
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $1.1 Million - $1.24 Million	-19,980 Reduced 4.42%	432,239 $26.8 Million
Q2 2018 Jul 12, 2018	SELL	$50.53 - $62.98 $468,160 - $583,509	-9,265 Reduced 2.01%	452,219 $25 Million
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $152,017 - $175,002	2,537 Added 0.55%	461,484 $29.2 Million
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $4.2 Million - $4.57 Million	70,001 Added 18.0%	458,947 $28.1 Million
Q3 2017 Nov 07, 2017	BUY	$55.23 - $63.74 $38,605 - $44,554	699 Added 0.18%	388,946 $24.8 Million
Q2 2017 Aug 08, 2017	BUY	N/A	388,247	388,247 $21.6 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account